More
    - Advertisement - spot_img
    HomeNewsRoche Shares Promising Phase IIb PADOVA Study Results for Prasinezumab in Early-Stage...

    Roche Shares Promising Phase IIb PADOVA Study Results for Prasinezumab in Early-Stage Parkinson’s Disease